These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24068567)

  • 41. Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses.
    Dewan R; Dewan A; Jindal M; Bhardawaj M
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1103-1108. PubMed ID: 31030480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic value of human epididymis protein 4 in endometrial cancer and its utility for surgical staging.
    Minar L; Klabenesova I; Jandakova E; Zlamal F; Bienertova-Vasku J
    J Obstet Gynaecol Res; 2015 Oct; 41(10):1644-52. PubMed ID: 26223178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physiopathological factors affecting the diagnostic value of serum HE4-test for gynecologic malignancies.
    Qu W; Li J; Duan P; Tang Z; Guo F; Chen H; Zhu X; Jiang SW
    Expert Rev Mol Diagn; 2016 Dec; 16(12):1271-1282. PubMed ID: 27784171
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Value of Tumor Markers].
    Nyangoh-Timoh K; Bendifallah S; Dion L; Ouldamer L; Levêque J
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):277-286. PubMed ID: 32004789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HE4 as a Biomarker for Endometrial Cancer.
    Behrouzi R; Barr CE; Crosbie EJ
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human epididymis protein 4 in endometrial cancer: A meta-analysis.
    Li LM; Zhu YX; Zhong Y; Su T; Fan XM; Xi Q; Li MY; Fu J; Tan H; Liu S
    Clin Chim Acta; 2018 Jul; 482():215-223. PubMed ID: 29630870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The diagnostic accuracy of human epididymis protein 4 (HE4) for discriminating between benign and malignant pelvic masses: a systematic review and meta-analysis.
    Olsen M; Lof P; Stiekema A; van den Broek D; Wilthagen EA; Bossuyt PM; Lok CAR
    Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1788-1799. PubMed ID: 34212386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The diagnostic, prediction of postoperative recurrence and prognostic value of HE4 in epithelial ovarian cancer.
    Chen L; Yang X; Abasi X; Shapaer G; Aizimu A; Zhang S; Wan Y; Kamaer X; Tuerxun T; Abula R; Zhang Q
    J BUON; 2018; 23(2):428-432. PubMed ID: 29745088
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum HE4 Level as a Biomarker to Predict the Recurrence of Gynecologic Cancers.
    Li J; Chen H; Curcuru JR; Patel S; Johns TO; Patel D; Qian H; Jiang SW
    Curr Drug Targets; 2017; 18(10):1158-1164. PubMed ID: 28382859
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Importance of Preoperative Knowledge of the Biomarker HE4 in Early-stage Endometrial Cancer Regarding Surgical Management.
    Presl J; Ovesna P; Novotny Z; Vlasak P; Bouda J; Kostun J; Topolcan O; Kucera R; Bednarikova M; Weinberger V
    Anticancer Res; 2017 May; 37(5):2697-2702. PubMed ID: 28476847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.
    Li F; Tie R; Chang K; Wang F; Deng S; Lu W; Yu L; Chen M
    BMC Cancer; 2012 Jun; 12():258. PubMed ID: 22712526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical value of combined detection of serum human epididymal secretory protein E4 and CA(125) in the diagnosis of endometrial carcinoma].
    Zhang AM; Zhang P
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):125-8. PubMed ID: 22455745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma.
    Deng L; Gao Y; Li X; Cai M; Wang H; Zhuang H; Tan M; Liu S; Hao Y; Lin B
    J Exp Clin Cancer Res; 2015 Sep; 34(1):96. PubMed ID: 26362938
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature.
    Capriglione S; Luvero D; Plotti F; Terranova C; Montera R; Scaletta G; Schirò T; Rossini G; Benedetti Panici P; Angioli R
    Med Oncol; 2017 Aug; 34(9):164. PubMed ID: 28825178
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients.
    Bignotti E; Ragnoli M; Zanotti L; Calza S; Falchetti M; Lonardi S; Bergamelli S; Bandiera E; Tassi RA; Romani C; Todeschini P; Odicino FE; Facchetti F; Pecorelli S; Ravaggi A
    Br J Cancer; 2011 Apr; 104(9):1418-25. PubMed ID: 21468050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer.
    Bian J; Sun X; Li B; Ming L
    Technol Cancer Res Treat; 2017 Aug; 16(4):435-439. PubMed ID: 27562869
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review.
    Scaletta G; Plotti F; Luvero D; Capriglione S; Montera R; Miranda A; Lopez S; Terranova C; De Cicco Nardone C; Angioli R
    Expert Rev Anticancer Ther; 2017 Sep; 17(9):827-839. PubMed ID: 28756722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma.
    Saarelainen SK; Peltonen N; Lehtimäki T; Perheentupa A; Vuento MH; Mäenpää JU
    Am J Obstet Gynecol; 2013 Aug; 209(2):142.e1-6. PubMed ID: 23583212
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The value of 18F-FDG PET/CT imaging combined with detection of CA125 and HE4 in the diagnosis of recurrence and metastasis of ovarian cancer.
    Sun J; Cui XW; Li YS; Wang SY; Yin Q; Wang XN; Gu L
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7276-7283. PubMed ID: 32706065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome.
    Zanotti L; Bignotti E; Calza S; Bandiera E; Ruggeri G; Galli C; Tognon G; Ragnoli M; Romani C; Tassi RA; Caimi L; Odicino FE; Sartori E; Pecorelli S; Ravaggi A
    Clin Chem Lab Med; 2012 Dec; 50(12):2189-98. PubMed ID: 23096757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.